- Home
- AYRO vs SPRC Comparison
AYRO vs SPRC Comparison
Compare AYRO & SPRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AYRO
- SPRC
- Stock Information
- Founded
- AYRO 2017
- SPRC 2004
- Country
- AYRO United States
- SPRC Israel
- Employees
- AYRO N/A
- SPRC N/A
- Industry
- AYRO Telecommunications Equipment
- SPRC Biotechnology: Pharmaceutical Preparations
- Sector
- AYRO Consumer Discretionary
- SPRC Health Care
- Exchange
- AYRO Nasdaq
- SPRC Nasdaq
- Market Cap
- AYRO 3.7M
- SPRC 3.0M
- IPO Year
- AYRO N/A
- SPRC N/A
- Fundamental
- Price
- AYRO $7.08
- SPRC $4.63
- Analyst Decision
- AYRO
- SPRC
- Analyst Count
- AYRO 0
- SPRC 0
- Target Price
- AYRO N/A
- SPRC N/A
- AVG Volume (30 Days)
- AYRO 77.1K
- SPRC 42.7K
- Earning Date
- AYRO 08-14-2025
- SPRC 01-01-0001
- Dividend Yield
- AYRO N/A
- SPRC N/A
- EPS Growth
- AYRO N/A
- SPRC N/A
- EPS
- AYRO N/A
- SPRC N/A
- Revenue
- AYRO $5,426.00
- SPRC $1,306,000.00
- Revenue This Year
- AYRO N/A
- SPRC N/A
- Revenue Next Year
- AYRO N/A
- SPRC N/A
- P/E Ratio
- AYRO N/A
- SPRC N/A
- Revenue Growth
- AYRO N/A
- SPRC N/A
- 52 Week Low
- AYRO $5.17
- SPRC $4.00
- 52 Week High
- AYRO $15.28
- SPRC $37.59
- Technical
- Relative Strength Index (RSI)
- AYRO 54.00
- SPRC 35.46
- Support Level
- AYRO $5.73
- SPRC $4.13
- Resistance Level
- AYRO $7.03
- SPRC $4.90
- Average True Range (ATR)
- AYRO 0.67
- SPRC 0.52
- MACD
- AYRO -0.01
- SPRC -0.07
- Stochastic Oscillator
- AYRO 61.14
- SPRC 31.88
About AYRO AYRO Inc.
AYRO Inc designs and manufactures compact, sustainable electric vehicles for closed campus mobility, low-speed urban and community transport, local on-demand and last-mile delivery, and government use. It operates as one reportable segment, focusing on the manufacturing and sales of environmentally-conscious, minimal-footprint EVs.
About SPRC SciSparc Ltd.
SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.